Alinea Pharmaceuticals Inc.
www.alineapharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Alinea Pharmaceuticals Inc.
Start-Up Previews (12/05)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The Double-edged Sword of Diabetes Drug Development, features profiles of Alba Therapeutics, Alinea, DiaKine and Diabetica. Plus these Start-Ups Across Health Care: Actimis, Luminous Medical, NABsys and Pathfinder Therapeutics.
The Double-edged Sword of Diabetes Drug Development
Intense interest in new diabetes drugs gives start-ups many choices for technology development or in-licensing, but recent regulatory caution also increases risk.
Alinea Pharmaceuticals Inc.
Alinea Pharmaceuticals was founded recently around three in-licensed development programs, encompassing a Phase II-ready molecule to treat diabetic complications, a set of leads against a novel serum glucose-regulating target of significant interest to Big Pharma, and a research program around novel methods for lipid control.
Selected Start-Ups (11/05)
In Vivo briefly summarizes the technologies of these recently founded companies: Alinea Pharmaceuticals, Neuronascent, Satori Pharmaceuticals, Stokes Bio, Tigris Pharmaceuticals and Triage Wireless.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice